Press Releases
Biotech Firm Continues Focus on Saving Lives Through First-of-its-Kind Residual Product, Expands Globally
Plano-based Allied BioScience Responds to Global Demand for First-of-its-kind Residual Product, Expansion of Product Portfolio
DALLAS (March 30, 2021) — Allied BioScience is growing significantly as the innovative biotech firm commits to expanding regulatory approvals for the use of SurfaceWise2™ nationally and abroad to meet demand while diversifying the lineup of products beyond antimicrobial surface coatings.
As global demand for SurfaceWise2 continues to expand, the company has strategic partnerships in Canada, Germany, Australia, India and the United Arab Emirates, with more in the pipeline. Spanning industries including transportation, healthcare, fitness and retail, leading partners in these countries plan to distribute and apply the surface coating.
“Allied BioScience has been committed to reducing the global burden of infectious disease for over a decade, but we’re especially proud of the innovation over the past year,” said Michael Ruley, CEO of Allied BioScience. “We remain focused on our mission as we expand globally, providing SurfaceWise2 to nations as part of the fight against COVID-19 and other viruses, and continue to diversify our products to keep our friends and families safer in new ways.”
Following initial emergency use authorization for SurfaceWise2 in the State of Texas by the Environmental Protection Agency, the company continues to work closely with the agency to increase access to the revolutionary residual COVID-19-fighting solution. The EPA recently announced the expansion of this authorization for the states of Oklahoma and Arkansas, as well as an approved extended residual efficacy of 30 days. Broad, national approval is expected in the coming months.
The company recently relocated its Plano headquarters to a new office space with nearly double its previous square footage to account for anticipated team expansion and plans to expand offerings outside of its flagship surface coatings in 2021.
About Allied BioScience
Allied BioScience is a disruptive biotechnology company specializing in continuously active antimicrobial coatings providing 90 days of surface protection. Working across various industries and commercial settings, its customers include health systems, sports facilities, and other commercial partners.
The company is dedicated to saving life through revolutionary science and focuses on developing innovative solutions to create cleaner human environments through long-lasting, always-on antimicrobial coatings.
Visit www.alliedbioscience.com for more information on the company.
About SurfaceWise2™
SurfaceWise2™ is the first and only continuously active antimicrobial surface coating authorized by the EPA to provide long-lasting, 30-day protection against viruses and bacteria, including SARS-CoV-2, with a single application. The revolutionary product was built upon Allied BioScience’s EPA-registered SurfaceWise™, the first generation, patented, transparent antimicrobial coating proven to prevent the growth of bacteria, fungi, and algae.
These products do not protect users or others against food-borne or disease-causing bacteria or fungi. It is a violation of federal law to use these products in a manner inconsistent with the labeling.
Visit www.surfacewise.com for more information on the groundbreaking product.
Media Contact:
Jenna Oltersdorf, Snackbox
[email protected]
Industry-leading Biotech Firm Allied BioScience Moves Plano Offices to Support Growing Team
Allied BioScience Plans to Expand Team to Support National Distribution of First-of-its-kind Residual Antimicrobial Coating, Extension of Product Portfolio
DALLAS (Feb. 4, 2021) — Local biotech firm Allied BioScience is relocating its Dallas-Fort Worth headquarters within Plano to provide ample space for the growing team as the company continues to create products that fight the global burden of infectious disease.
“The expansion of Allied BioScience, a homegrown Plano company, is further evidence that we are a city of excellence and innovation,” said Harry LaRosiliere, Mayor of Plano. “Plano is excited to see Allied BioScience grow their footprint as they develop a game-changing solution to fight the spread of infectious diseases.”
JLL brokered the deal, doubling the square footage from Allied BioScience’s previous office space. The company is also planning to move its research and development labs into a larger space to support its product line’s robust diversification.
The recent, significant momentum of the 12-year-old biotechnology pioneer increased its staffing needs. The company plans to hire across all departments this year to support significant sales increases following broader Environmental Protection Agency (EPA) authorization for use across the country this quarter, as well as an expansion beyond the suite of surface coatings to diversify its product offerings in the coming months.
“For well over a decade, Allied BioScience has remained committed to fighting the global burden of infectious disease, and the past year has been our most exciting to date as we worked alongside the Environmental Protection Agency and other leaders to fight SARS-CoV-2,” said Michael Ruley, CEO, Allied BioScience. “This year, we expect tremendous, continued growth and are excited to have found the perfect space for our team as they continue their essential work in bringing antimicrobial technology to businesses across the U.S.”
The move comes after the company’s groundbreaking surface coating SurfaceWise2 became the first-ever antiviral product to receive EPA approval to continuously protect against COVID-19 with a single application in August of 2020. The product is also proven in independent lab studies and field trials to provide the same residual defense against other threatening viruses and bacteria, including Staphylococcus, Pseudomonas and Klebsiella.
For additional information on the revolutionary SurfaceWise2, visit www.surfacewise.com.
About Allied BioScience
Allied BioScience is a disruptive biotechnology company specializing in continuously active antimicrobial coatings providing 90 days of surface protection. Working across various industries and commercial settings, its customers include health systems, sports facilities, and other commercial partners.
The company is dedicated to saving life through revolutionary science and focuses on developing innovative solutions to create cleaner human environments through long-lasting, always-on antimicrobial coatings.
Visit www.alliedbioscience.com for more information on the company.
About SurfaceWise2™
SurfaceWise2™ is the first and only continuously active antimicrobial surface coating authorized by the EPA to provide long-lasting, 30-day protection against viruses and bacteria, including SARS-CoV-2, with a single application. The revolutionary product was built upon Allied BioScience’s EPA-registered SurfaceWise™, the first generation, patented, transparent antimicrobial coating proven to prevent the growth of bacteria, fungi, and algae.
These products do not protect users or others against food-borne or disease-causing bacteria or fungi. It is a violation of federal law to use these products in a manner inconsistent with the labeling.
Visit www.surfacewise.com for more information on the groundbreaking product.
Media Contact:
Jenna Oltersdorf, Snackbox
[email protected]
Administrator Wheeler Kicks Off Region 6 Visit in Texas
DALLAS (November 18, 2020) — While in Texas, U.S. Environmental Protection Agency (EPA) Administrator Andrew Wheeler viewed an American Airlines disinfecting demonstration thanks to EPA’s first-ever long-lasting antiviral product for use against COVID-19. While in the Lone Star State Administrator Wheeler also visited the Region 6 office in downtown Dallas.
“EPA had to adapt to the coronavirus outbreak by creating a new permitting process that could allow innovative new products to be quickly and effectively tested and deemed safe for use,” said EPA Administrator Andrew Wheeler. “This long-lasting disinfectant is a great innovation and could help the aviation industry in the coming months.”
“At EPA, we are committed to combatting the spread of the coronavirus through innovative solutions, and expedited approvals of disinfectants that kill the virus so more Americans and businesses can have greater access to EPA-approved solutions,” said EPA Regional Administrator Ken McQueen. “It was an honor to welcome Administrator Wheeler to Region 6 to see first-hand one of the latest examples of the tools being used to protect human health.”
During the demonstration, Administrator Wheeler viewed electrostatic spraying of SurfaceWise 2 in the galley and first-class cabin of a 737 plane.
In August, EPA announced a groundbreaking development in the current Administration’s efforts to combat the novel coronavirus. In a first-of-its kind step, EPA issued an emergency exemption to the state of Texas permitting it to allow American Airlines and Total Orthopedics Sports & Spine to use a new product that kills coronavirus like the SARS-CoV-2 virus on surfaces for up to seven days. After carefully reviewing the available data and information, the agency has determined that the product helps to address the current national emergency. This product is expected to provide longer-lasting protection in public spaces, increasing consumer confidence in resuming normal air travel and other activities.
EPA approved the emergency exemption requests submitted under Section 18 of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). SurfaceWise2 — a product manufactured by Allied BioScience completely in the United States — is a surface coating that inactivates viruses and bacteria within two hours of application and continues to work against them for up to seven days. EPA’s approval allowed Texas to permit American Airlines airport facilities and planes at specific locations and two Total Orthopedics Sports & Spine Clinics to use SurfaceWise2 under certain conditions.
In October, EPA released a draft guidance to ensure that Americans have access to as many tools as possible to clean and disinfect surfaces and protect their families against the novel coronavirus. Through the draft guidance companies will now be able to demonstrate that their products have “long-lasting” or “residual” effectiveness on surfaces against viruses like SARS-CoV-2, the coronavirus that causes COVID-19.
While traditional disinfectants only kill viruses and bacteria that are on the surface at the time they are used, surfaces treated with residual antimicrobial products kill pathogens that come into contact with the surface days, weeks, or years after the product is applied. EPA will begin expediting the registration process for these products immediately and may revise the guidance after the 60-day public comment period ends.
The guidance specifies scientific testing requirements for two different types of products: supplemental residual antimicrobial products and residual disinfectants. Supplemental residual antimicrobial products work within two hours of a virus or bacteria coming into contact with a surface and can remain effective for weeks to years. These products can supplement, but do not replace, routine cleaning and disinfection using products from EPA’s List N: Disinfectants for Use Against SARS-CoV-2 (List N). Approved supplemental residual antimicrobial products are not eligible for inclusion on List N but will be added to a separate List N appendix.
Administrator Wheeler views an American Airlines disinfecting demonstration with SurfaceWise 2.
Administrator Wheeler meets with American Airlines leadership on COVID-19 disinfectants.
Media Contact:
Jenna Oltersdorf, Snackbox
[email protected]
Allied BioScience Signs Contract with SOCOMORE to Manufacture SurfaceWise2™ for North American and Global Market
DALLAS (Nov. 03, 2020) — Allied BioScience has signed a contract manufacturing agreement with SOCOMORE to manufacture SurfaceWise2™ through SOCOMORE’s wholly-owned, Texas-based subsidiary.
Dysol has a long history in North American aerospace manufacturing, supplying original equipment manufacturer (OEM) and maintenance, repair and overhaul (MRO) facilities with proprietary products including specialty coatings, critical cleaning solvents, airframe shims and an extensive line of surface preparation products, manufactured to AS9100/ISO 9001 standards.
“We are delighted to announce our strategic partnership with Allied BioScience to support the manufacture and delivery of this game-changing product,” said Andrew Leech, President of Dysol. “This opportunity allows us to leverage our world-class manufacturing capability while aligning with Allied BioScience in our common goal to provide sustainable solutions that make a difference in people’s daily lives.”
The partnership follows the initial EPA approval of SurfaceWise2 in late August for use by American Airlines and a Texas-based sport and spine clinic to continuously protect against COVID-19 on surfaces. Dysol will initially manufacture and distribute SurfaceWise2 to Allied BioScience’s Texas-based customers as the company works closely with the EPA to expand approval for broader, national use.
“We are proud to partner with SOCOMORE and Dysol and trust them to manufacture the first and only continuously active antiviral surface coating approved by the EPA for use in Texas,” said Michael Ruley, CEO, Allied BioScience. “They bring vast experience in surface preparation, treatment and protection as we continue bringing SurfaceWise2 to market to provide additional protection against COVID-19 and other viruses and bacteria.”
SurfaceWise2 has undergone rigorous reviews, determining the product carries the lowest toxicity rating by the EPA and ensuring it is very safe for humans, even in enclosed spaces. The solution is non-toxic, non-irritating, odorless and contains no chemicals that produce harmful vapors or gases.
SurfaceWise2 is intended for use in tandem with other safety measures, including regular cleaning, wearing masks, and proper social distancing. However, it replaces the need for constant COVID-style deep cleans, allowing facilities to return to more typical, pre-COVID cleaning schedules, making it much more efficient to keep high-traffic facilities safe.
For additional information, visit www.alliedbioscience.com.
About Allied BioScience
Allied BioScience is a disruptive biotechnology company dedicated to saving lives and livelihoods through revolutionary science and focuses on developing innovative solutions to create cleaner human environments through long-lasting, always-on antimicrobial coatings.
SurfaceWise2™ is the first-of-its-kind long-lasting product approved by the EPA to help fight the spread of the novel coronavirus. This continuously-active surface coating is applied electrostatically to provide always-on protection on treated surfaces.
Visit www.AlliedBioScience.com for more information.
About SOCOMORE
Headquartered in Vannes, France, SOCOMORE designs, manufactures and markets specialty solutions for critical aerospace operations with a focus on environmental responsibility. Dysol is a wholly owned subsidiary of SOCOMORE and headquartered in Rhome, Texas. Dysol has a long history in North American aerospace manufacturing. Dysol supplies qualified products for major OEMs including Airbus, Boeing, and Lockheed Martin, as well as specialty solutions for MRO facilities with its proprietary products including coatings (Aeroglaze and Chemglaze), critical cleaning solvents (Diestone and DS), Dynamold liquid shims and an extensive line of surface preparation products. Visit www.Socomore.com for more information.
Media Contact:
Jenna Oltersdorf, Snackbox
[email protected]
SurfaceWise2 Becomes First Antiviral Surface Coating Approved by EPA to Continuously Protect Against COVID-19 With a Single Application
Allied BioScience’s Next-Generation Coating Provides Crucial Surface Protection
in Fight Against COVID-19 as Texas Businesses Reopen
DALLAS (August 24, 2020) — In response to COVID-19, the U.S. Environmental Protection Agency (EPA) today approved a public health emergency exemption waiver for Allied BioScience submitted by the Texas Department of Agriculture. The approval allows the use of SurfaceWise among Texas-based customers to provide continuous effectiveness in protecting against SARS-CoV-2, the virus that causes COVID-19.
Allied BioScience’s SurfaceWise2 coating is now the first and only surface coating approved by the EPA for use to continuously protect against COVID-19 with a single application. With the EPA’s approval, the Texas Department of Agriculture received an exemption enabling Texas to become the first state in which a Section 18 emergency waiver for SurfaceWise2 has been approved. Allied BioScience is pursuing this emergency waiver across all 50 states.
“The EPA approval clears the way to begin effectively protecting consumers against COVID-19 as the only solution proven to provide long-term, non-toxic surface protection from the virus,” said Michael Ruley, CEO, Allied BioScience. “We have been eager to bring our product to market and look forward to partnering with leading Texas-based companies to keep Texans safe in the fight against COVID-19.”
SurfaceWise2 is the latest surface coating from Allied BioScience with antiviral properties that continuously kill 99.9% of viruses on surfaces. The non-toxic coating is applied via an electrostatic spray to provide always-on protection on treated surfaces.
Independent lab studies conducted ahead of the emergency waiver approval by leading infectious disease expert Dr. Charles Gerba found SurfaceWise2 to be effective against Human Coronavirus 229E, the EPA approved surrogate for 90 days. This demonstrates the ability to protect against COVID-19 successfully.
About Allied BioScience
Allied BioScience is a disruptive biotechnology company dedicated to saving lives and livelihoods through revolutionary science and focuses on developing innovative solutions to create cleaner human environments through long-lasting, always-on antimicrobial coatings.
SurfaceWise2 is the first-of-its-kind long-lasting product approved by the EPA to help fight the spread of the novel coronavirus. This continuously-active surface coating is applied electrostatically to provide always-on protection on treated surfaces.
Read more about the life-saving product, directly from the EPA’s Press Release – here.
Media Contact:
Jenna Oltersdorf, Snackbox
[email protected]
EPA Approves First-Ever Long-Lasting Antiviral Product for Use Against COVID-19
08/24/2020
WASHINGTON (August 24, 2020) — Today, U.S. Environmental Protection Agency (EPA) Administrator Andrew Wheeler announced a groundbreaking development in the government’s efforts to combat the novel coronavirus. In a first-of-its kind step, EPA has issued an emergency exemption to the state of Texas permitting it to allow American Airlines and Total Orthopedics Sports & Spine to use a new product that kills coronavirus like the SARS-CoV-2 virus on surfaces for up to seven days. After carefully reviewing the available data and information, the agency has determined that the product helps to address the current national emergency. This product is expected to provide longer-lasting protection in public spaces, increasing consumer confidence in resuming normal air travel and other activities.
“There is no higher priority than protecting the health and safety of Americans and I want to thank those who have worked with us to achieve this major milestone,” said EPA Administrator Andrew Wheeler. “Since day one, I have been committed to ensuring that Americans have as many tools as possible to protect their families and today we are delivering on that promise by approving the first-ever long-lasting antiviral product that will help fight the spread of the novel coronavirus.”
“Texas is proud to once again step up and join the fight against this virus,” said Texas Agriculture Commissioner Sid Miller. “This Section 18 exemption gives businesses another tool to protect consumers as we try to bring our economy back. Thank you to the EPA Administrator Wheeler for your commitment to the safety of the American people and to ending this pandemic that is choking our economy and our way of life.”
“We are very grateful for Administrator Wheeler and the many hardworking professionals at the EPA who rigorously evaluated SurfaceWise2 to safeguard our customers and team members from viruses, such as the flu and coronavirus,” said American Airlines Chief Operating Officer David Seymour. “SurfaceWise2 will make the travel experience even safer for those who are ready to return to the skies and reopen our country for business.”
“We are thrilled to work closely with the EPA on approval for SurfaceWise2, which enables people to get back to living their lives,” said Allied BioScience CEO Michael Ruley. “This initial EPA approval clears the way to effectively protect people against COVID-19 as a residual solution proven to provide long-term, non-toxic surface protection from viruses, including coronaviruses. We know how tirelessly the EPA has worked to evaluate a litany of innovative products, and we are excited to provide this added layer of defense for our country.”
EPA is approving the emergency exemption requests submitted under Section 18 of the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA). SurfaceWise2—a product manufactured by Allied BioScience completely in the United States—is a surface coating that inactivates viruses and bacteria within two hours of application and continues to work against them for up to seven days. EPA’s approval will allow Texas to permit American Airlines airport facilities and planes at specific locations and two Total Orthopedics Sports & Spine Clinics to use SurfaceWise2 under certain conditions.
Over the coming months, Allied BioScience will pursue a non-emergency approval under FIFRA Section 3 by submitting additional data to meet EPA’s registration requirements as an antiviral surface coating. If the full registration process is completed, the product would become available for purchase by members of the public.
EPA anticipates posting information for companies or individuals who are interested in pursuing a FIFRA Section 3 registration for antiviral surface coatings in the coming weeks. In the interim, states or federal agencies interested in pursuing a Section 18 Emergency Exemption Request for products that claim residual efficacy against viruses for up to seven days should be prepared to include efficacy data demonstrating that the product is durable and effective against viruses in their applications. Durability and efficacy should both be evaluated. For example, antiviral efficacy should be assessed using coated surfaces that have been exposed to physical touches/abrasion and treatment with disinfectants. EPA will review the results of these studies to ensure that surface coatings remain effective under the anticipated proposed conditions of use.
For more information, please visit: https://www.epa.gov/pesticide-registration/section-18-emergency-exemption-requests-and-coronavirus-covid-19
Background
SurfaceWise2 is meant to inactivate viruses that land on a surface between regular cleanings. This product is not a replacement for routine cleaning and disinfection with products from EPA’s List N: Disinfectants for Use Against SARS-CoV-2, the virus that causes COVID-19. EPA recommends that facilities continue to follow the cleaning and disinfection recommendations from the Centers for Disease Control and Prevention (CDC). Please note that according to the CDC, while “it may be possible that a person can get COVID-19 by touching a surface or object that has the virus on it and then touching their own mouth, nose, or possibly their eyes,” the virus is thought to spread mainly through close contact between individuals.
The approved Section 18 emergency requests are effective for a year. As new data emerge, EPA may alter the terms of the product’s emergency uses.
Continuously Active Surface Disinfectants May Provide Additional Barrier Against the Spread of Viruses
As the novel coronavirus pandemic continues, UArizona researchers are evaluating the potential of antiviral surface coatings in continued defense against the environmental spread of viruses.
Tucson, AZ
May 15, 2020
While disinfecting high-contact surfaces is an important practice to prevent the spread of pathogens, these surfaces can be easily re-contaminated after the use of conventional surface disinfectants. Alternatively, continuously active disinfectants work to actively kill microorganisms and provide continued protection over an extended period of time.
[Read University of Arizona Article] (University of Arizona Website)
Allied BioScience Appoints Three-Time Super Bowl Champion and NFL Analyst Daryl Johnston as Senior Advisor, Sports Marketing
The retired Dallas Cowboys fullback brings sports management expertise to the table as professional facilities and arenas look to re-open amidst the COVID-19 pandemic
Plano, TX
May 08, 2020
Allied BioScience, a Dallas-based biotechnology company specializing in novel antimicrobial coatings designed to reduce infection and illness across public spaces, announced today that Daryl Johnston has joined the firm as Senior Advisor of Sports Marketing, effective immediately. A former fullback for the Dallas Cowboys and current NFL analyst with FOX Sports, Mr. Johnston will focus on Allied BioScience’s business growth as it looks to expand into the sports industry and other diversified sectors.
[READ MORE]
First Healthcare-Associated Infection Reduction Tied to Use of 90-Day Antimicrobial Coating, Study Indicates
Always-On™ surface coating demonstrates first correlation of sustained environmental bioburden reduction and 36% Healthcare-Associated Infection (HAI) declines.
Plano, TX
April 28, 2020
A new study published in Clinical Infectious Diseases finds a patented continuously active antimicrobial coating used in two high-acuity hospitals has produced the first-ever association between sustained environmental bioburden decreases (79% and 75%, respectively) and Healthcare-Associated Infections (HAI) reductions – 36% across both sites. The continuous antimicrobial coating is the first-generation product developed by Dallas-based biotechnology company, Allied BioScience.
[READ MORE]
Lydia Partners Invests in Allied BioScience to Scale Operations, Meet Demand
Rab Shanableh joins Board of Directors as Demand Surges for Disruptive Infection Prevention for Public Spaces
Plano, TX
April 2, 2020
Allied BioScience, a Dallas-based biotechnology company specializing in novel antimicrobial coatings designed to reduce infection and illness across public spaces, announced today that Lydia Partners’ Managing Director Mohammed “Rab” Shanableh has been appointed to its Board of Directors. Allied BioScience also announced that it is among Lydia Partners’ initial round of multimillion-dollar investments in consumer technology, healthcare, and biomedical ventures.
[READ MORE]
